Normal
23rd - 24th June 2022

4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference

Boston, USA

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 4th Annual MarketsandMarkets Next Gen Bioprocessing Conference.

We will launching this physical meet in Boston, USA that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 23rd - 24th June 2022.

Learn from the leading experts of the industry about strategies, technologies and innovations in the area of bioprocessing of cell-gene therapies.

Co-Related Conferences
WHAT TO EXPECT
Key Highlights
  • Cell culture through dimensional process
  • Lentiviral bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • CMC considerations for NK cells
  • Supply chain and regulatory issues
Why Attend ?
  • Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods.
  • Participate in discussions with experts on how technology implementation can be improved.
  • Attracting and retaining world-class pharma and biotech talent.
  • Resolve common contamination and R&D challenges.
  • Discover the latest technology implementations in the industry.
  • Discover best-in-class solutions during the workshop sessions.
Who Should Attend ?

CEO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Investigators, Heads, Managers, Principal scientists, Scientists, Professors, Lecturers, Group Heads, Researchers from Pharmaceuticals/Therapeutics/Cell-Gene therapy-based companies working on :

• Bioprocess development      • GMP/Manufacturing
• Cellular Therapy                   • Gene Therapy 
• Cell Engineering                   • Cell culture operations
• mRNA type therapeutics       • ATMP (Advanced therapy medicinal products)
 

CONFERENCE AGENDA
ADVANCES IN CELL AND GENE THERAPY
VACCINE AND MRNA THERAPEUTICS
CONFERENCE SPEAKERS
Advisors
Tuhin Bhowmick

Tuhin Bhowmick

Founder & CEO
Pandorum Int.

Tuhin Bhowmick

Founder & CEO
Pandorum Int.
David Gemmell

David Gemmell

MSAT Biomanufacturing Engineer
Merck

David Gemmell

MSAT Biomanufacturing Engineer
Merck
Speakers
Tuhin Bhowmick

Tuhin Bhowmick

Founder & CEO
Pandorum Int.

Tuhin Bhowmick

Founder & CEO
Pandorum Int.
David Gemmell

David Gemmell

MSAT Biomanufacturing Engineer
Merck

David Gemmell

MSAT Biomanufacturing Engineer
Merck
Prasun Mishra

Prasun Mishra

Chief Executive Officer
Precision Biopharma

Prasun Mishra

Chief Executive Officer
Precision Biopharma
David Wood

David Wood

Professor
The Ohio State University

David Wood

Professor
The Ohio State University
Ehsan Mahdinia

Ehsan Mahdinia

Assistant Professor
CBET-ACPHS

Ehsan Mahdinia

Assistant Professor
CBET-ACPHS
Jared Auclair

Jared Auclair

Associate Dean of Professional Program and Graduate Affairs
Northeastern University

Jared Auclair

Associate Dean of Professional Program and Graduate Affairs
Northeastern University
Laurens Vergauwen

Laurens Vergauwen

EMEA Process Development Scientist
Merck

Laurens Vergauwen

EMEA Process Development Scientist
Merck
Erik Liu

Erik Liu

Process Development Scientist , Drug Substance Technologies
Amgen

Erik Liu

Process Development Scientist , Drug Substance Technologies
Amgen
SPONSORS
Silver
example-image

CYROPDP

example-image

Cellex

Speaking Partner
example-image

BIA Separations

PARTNERS
Media Partners
example-image

Bentham Science

LOCATION
Boston, USA
About the Hotel

PAST EVENT GALLERY